Clinical Trial

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Name: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD — clinical trial record (NCT05624268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Protocol Amendment History 1 change

critical Trial completed 2026-08-11

Trial Details

NCT Number	NCT05624268
Lead Sponsor	COMPASS Pathways
Conditions	Treatment Resistant Depression
Enrollment	258 participants
Start Date	2023-01-24
Primary Completion	2025-05-28 (estimated)
Study Completion	2026-04-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-10